Actinium Pharmaceuticals Inc. buy BiotechBee
Start price
04.02.24
/
60%
€4.84
Target price
31.10.25
€7.00
Performance (%)
40.19%
Price
30.04.24
€7.19
Summary
This prediction is currently active. With a performance of 40.19% the BUY prediction by BiotechBee is a big success. This prediction currently runs until 31.10.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Actinium Pharmaceuticals Inc. | 11.214% | 11.214% |
iShares Core DAX® | -1.370% | -3.231% |
iShares Nasdaq 100 | 0.172% | -3.339% |
iShares Nikkei 225® | -0.801% | -7.859% |
iShares S&P 500 | -0.369% | -2.979% |
According to BiotechBee what are the pros and cons of Actinium Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Actinium Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 7,0
Stopped prediction by BiotechBee for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.30
10.12.23
10.12.23
€6.00
31.05.25
31.05.25
-8.68%
04.02.24
04.02.24
Could be very worthwhile Investment >20% year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
06.02.23
06.02.23
€20.00
31.12.25
31.12.25
-29.20%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.47
31.10.22
31.10.22
€18.00
31.12.24
31.12.24
19.77%
31.10.22
31.10.22
Could be very worthwhile Investment >20% year